EXPERT REV MOL DIAGN

Publications

  1. 2022
  2. 2019
  3. The cellular prion protein and its derived fragments in human prion diseases and their role as potential biomarkers

    Thüne, K., Schmitz, M., Villar-Piqué, A., Altmeppen, H. C., Schlomm, M., Zafar, S., Glatzel, M., Llorens, F. & Zerr, I., 11.2019, In: EXPERT REV MOL DIAGN. 19, 11, p. 1007-1018 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. 2015
  5. Liquid biopsy in cancer patients: advances in capturing viable CTCs for functional studies using the EPISPOT assay

    Alix-Panabières, C. & Pantel, K., 11.2015, In: EXPERT REV MOL DIAGN. 15, 11, p. 1411-7 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. Beyond cardiac troponin: Recent advances in the development of alternative biomarkers for cardiovascular disease

    Rubini Gimenez, M., Twerenbold, R. & Mueller, C., 01.04.2015, In: Expert Review of Molecular Diagnostics. 15, 4, p. 547-556 10 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  7. The potential of circulating nucleic acids as components of companion diagnostics for predicting and monitoring chemotherapy response

    Schwarzenbach, H., 02.2015, In: EXPERT REV MOL DIAGN. 15, 2, p. 267-75 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  8. The clinical relevance of circulating, exosomal miRNAs as biomarkers for cancer

    Schwarzenbach, H., 2015, In: EXPERT REV MOL DIAGN. 15, 9, p. 1159-69 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. 2003
  10. Tissue microarrays in cancer diagnosis.

    Simon, R., Mirlacher, M. & Sauter, G., 2003, In: EXPERT REV MOL DIAGN. 3, 4, p. 421-430 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review